Patient presents with a history of testicular cancer, diagnosed on [Date of Diagnosis] as [Specific Histologic Type, e.g., seminoma, non-seminoma, mixed germ cell tumor].  Initial presentation included [Symptoms at presentation, e.g., painless testicular mass, testicular swelling, scrotal heaviness, back pain].  Initial tumor markers were [e.g., AFP, beta-hCG, LDH] at [Values at diagnosis].  Staging workup, including [Imaging studies performed, e.g., scrotal ultrasound, CT scan of abdomen and pelvis, chest x-ray], revealed [Stage at diagnosis, e.g., Stage I, Stage II, Stage III].  Initial treatment consisted of [Treatment received, e.g., radical orchiectomy, retroperitoneal lymph node dissection (RPLND), chemotherapy regimen specified].  Patient reports [Current status, e.g., no evidence of disease, persistent disease, recurrence].  Current surveillance includes [Ongoing monitoring plan, e.g., physical exam, tumor marker monitoring, imaging studies] with frequency of [Frequency of follow-up]. Patient denies [Pertinent negatives, e.g., new or worsening symptoms, pain, swelling].  Physical exam reveals [Findings, e.g., normal scrotal examination, palpable mass, lymphadenopathy].  Assessment:  History of testicular cancer, [Current status, e.g., in remission, with persistent disease, recurrent]. Plan:  Continue current surveillance plan.  Patient education provided regarding the importance of adherence to the follow-up schedule and reporting any new or recurrent symptoms.  Differential diagnoses considered at initial presentation included [Differential diagnoses, e.g., epididymitis, orchitis, testicular torsion, spermatocele, hydrocele].  ICD-10 code: C62.9 (Malignant neoplasm of testis, unspecified) or specify other C62 code as appropriate.